EV Biologics, Inc. (YECO)

EV Biologics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	0.05	0	0.12	0	0
Gross Profit	0.05	0	0.12	0	0
Selling, General & Admin	0.53	0.59	0.14	0.1	0.1
Operating Expenses	0.53	0.59	0.14	0.1	0.1
Operating Income	-0.48	-0.59	-0.02	-0.1	-0.1
Other Expense / Income	0.78	20.47	0.36	0	0
Pretax Income	-1.27	-21.06	-0.39	-0.1	-0.1
Net Income	-1.27	-21.06	-0.39	-0.1	-0.1
Shares Outstanding (Basic)	10	7	7	7	6
Shares Outstanding (Diluted)	10	7	7	7	6
Shares Change	41.52%	-	-	12.45%	166.49%
EPS (Basic)	-0.12	-2.91	-0.05	-0.01	-0.02
EPS (Diluted)	-0.12	-2.91	-0.05	-0.01	-0.02
Free Cash Flow	-3.32	-20.84	-18.57	0.1	-0.38
Free Cash Flow Per Share	-0.32	-2.88	-2.57	0.01	-0.06
Gross Margin	100.00%	-	100.00%	-	-
Operating Margin	-987.85%	-	-20.40%	-	-
Profit Margin	-2591.28%	-	-326.07%	-	-
Free Cash Flow Margin	-6793.78%	-	-15616.47%	-	-
EBITDA	-0.48	-0.59	-0.02	-0.1	-0.1
EBITDA Margin	-987.85%	-	-20.40%	-	-
Depreciation & Amortization	0	0	0	0	0.69
EBIT	-	-	-	-	-0.79

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.